The University of Pennsylvania's Digestive Diseases Research Core Center (DDRCC), entitled Center for Molecular Studies in Digestive and Liver Diseases (CMSDLD), has been funded since 1997. This competing grant proposal continues to unite investigators from multiple disciplines for integrative digestive, live and pancreatic based research. The research base includes investigators organized in the following three interrelated scientific affinity groups: (l) Developmental biology and regenerative medicine, (2) lmmunobiology and host responses, and (3) Cell growth and differentiation. The research base consists of 58 members, with interrelated scientific programs, and represents a spectrum of Departments, Centers, Institutes, and Schools at the University of Pennsylvania and surrounding Institutions. In addition, there is a young investigator base of 11 associate members, whose own individual programs and career development are nurtured by the Center. Center members are supported by $27,301,051 in digestive-diseases related NIH research funding, of which 60% is through NIDDK. A fundamental goal of our Center is to foster interdisciplinary research that leads to a cooperative understanding of the molecular and biochemical processes that form, regulate, and operate digestive tract, pancreatic and liver organs and their organizing tissues in health and disease. In this context, our intent is to utiliz the Center as a means to develop innovative ideas by attracting and engaging established investigators into digestive, liver and pancreatic research. An equally important goal of the Center is to develop young investigators in this research. Four highly successful Scientific Core facilities are designed to provide digestive-specific services for the stimulation of collaborative research: Molecular Biology/Gene Expression, Molecular Pathology and Imaging, Transgenic and Chimeric Mouse and Cell Culture. An Administrative Core directs the fiscal and organizational aspects of the Center, including the coordination and publicity of the scientific cores, pilot and feasibility (P/F) grant program, academic enrichment program and Internal/External Advisory committees. Our DDRCC's aggregate functions maintain the digestive, liver and pancreatic programs at the forefront of biomedical science.

Public Health Relevance

The Penn DDRCC or CMSDLD comprises an integrated and interdisciplinary research base dedicated to the enhancement of our understanding of normal digestive, liver and pancreatic health as well as diseases that arise from these organs. Scientific core facilities, P/F grants and enrichment programs provide a rich platform of technologies, services and interactions to promote the collaborative research efforts of CMSDLD members and associate members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
4P30DK050306-20
Application #
9132224
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Perrin, Peter J
Project Start
1998-07-01
Project End
2017-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
20
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Karakasheva, Tatiana A; Dominguez, George A; Hashimoto, Ayumi et al. (2018) CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 3:
Uribe-Herranz, Mireia; Bittinger, Kyle; Rafail, Stavros et al. (2018) Gut microbiota modulates adoptive cell therapy via CD8? dendritic cells and IL-12. JCI Insight 3:
Facompre, Nicole D; Harmeyer, Kayla M; Sahu, Varun et al. (2018) Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget 9:8985-8998
Estrada, Michelle A; Zhao, Xiao; Lorent, Kristin et al. (2018) Synthesis and Structure-Activity Relationship Study of Biliatresone, a Plant Isoflavonoid That Causes Biliary Atresia. ACS Med Chem Lett 9:61-64
DeLong, Jonathan H; Hall, Aisling O'Hara; Konradt, Christoph et al. (2018) Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J Immunol 200:1761-1770
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Karakasheva, Tatiana A; Lin, Eric W; Tang, Qiaosi et al. (2018) IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. Cancer Res 78:4957-4970
Bengsch, Bertram; Ohtani, Takuya; Herati, Ramin Sedaghat et al. (2018) Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns. J Immunol Methods 453:3-10
Moreira, Leticia; Bakir, Basil; Chatterji, Priya et al. (2018) Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer. Cell Mol Gastroenterol Hepatol 5:289-298
Das, Koushik K; Heeg, Steffen; Pitarresi, Jason R et al. (2018) ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis. Dev Dyn 247:854-866

Showing the most recent 10 out of 700 publications